Zhong Zuo

10.7k total citations · 2 hit papers
247 papers, 8.5k citations indexed

About

Zhong Zuo is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Zhong Zuo has authored 247 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 62 papers in Pharmacology and 53 papers in Pharmacology. Recurrent topics in Zhong Zuo's work include Drug Transport and Resistance Mechanisms (28 papers), Natural product bioactivities and synthesis (24 papers) and Traditional Chinese Medicine Analysis (23 papers). Zhong Zuo is often cited by papers focused on Drug Transport and Resistance Mechanisms (28 papers), Natural product bioactivities and synthesis (24 papers) and Traditional Chinese Medicine Analysis (23 papers). Zhong Zuo collaborates with scholars based in Hong Kong, China and United States. Zhong Zuo's co-authors include Limin Zhou, Moses S. S. Chow, Ge Lin, Moses S.S. Chow, Zhang Li, Qi Chang, Yin Cheong Wong, Mengbi Yang, Chunbo Zhang and Chenrui Li and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Zhong Zuo

231 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

2005 1.1k citations Limin Zhou, Zhong Zuo et al. The Journal of Clinical Pharmacology profile →
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis

2023 155 citations Zhong Zuo et al. profile →

Peers

Countries citing papers authored by Zhong Zuo

Since Specialization

Citations

This map shows the geographic impact of Zhong Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong Zuo more than expected).

Fields of papers citing papers by Zhong Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong Zuo. The network helps show where Zhong Zuo may publish in the future.

Co-authorship network of co-authors of Zhong Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong Zuo. A scholar is included among the top collaborators of Zhong Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong Zuo. Zhong Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-photon dual-comb ghost imaging spectroscopy 2025 ·Nature Communications ·(unknown), Liang Mei, (unknown), Zhong Zuo, Zhiwei Liu, (unknown), Xü Liu, Chenglin Gu, Wenxue Li, (unknown)	0
2	A Comparative Study of the Clinical Efficacy of Superselective Adrenal Artery Embolization for Patients with Primary Aldosteronism 2025 ·American Journal of Hypertension ·Lili Wang, Rui Xiang, (unknown), Min Mao, Rui Feng, Ling Tao, Paul C. Tang, Yupei Zhao, Zhong Zuo, (unknown), Peng Pu, Wei Huang, Xiaoyu Li, Jia Chen, (unknown), Qiong Shi, Fajin Lv, (unknown), Niaz Ahmed Khan, Zhixin Xu	2
3	Biomimetic Platelet Membrane-Based Polyphenol–CeO₂ Nanozyme Complex: A Broad-Spectrum Antioxidative System for Comprehensive Atherosclerosis Treatment 2025 ·ACS Applied Materials & Interfaces ·Yao Chen, Qingfa Tang, Qingshan Zhu, Meiting Lu, (unknown), (unknown), Zidong Wang, Lu Zhang, Qiang Liu, (unknown), Zhong Zuo, Chunyan Shen, Cuiping Jiang	2
4	Bilateral superselective adrenal artery embolization for bilateral primary aldosteronism: a novel approach in an efficacy and safety proof-of-principle trial 2024 ·Hypertension Research ·Xin Li, Rui Feng, (unknown), Tao Li, (unknown), Ping Tang, Zhong Zuo, (unknown), (unknown), (unknown), (unknown), Jie Chen, (unknown), (unknown), Hong Zhao, (unknown), Yutian He, (unknown), Jing Chang, Min Mao	3
5	Atherosclerotic renal artery stenosis, mediating biomarkers, and risk of cardiac among individuals with hypertension: A real-world study 2024 ·IJC Heart & Vasculature ·Yanwei Li, (unknown), Rui Lan, Ran Tao, (unknown), Jialian Li, (unknown), (unknown), Zhong Zuo	2
6	Response of Seed Germination and Seedling Growth of Six Desert Shrubs to Different Moisture Levels under Greenhouse Conditions 2024 ·Biology ·(unknown), Yang Hui, (unknown), (unknown), (unknown), Jiazhi Wang, (unknown), Zhong Zuo, (unknown), (unknown)	0
7	Flexible Scaffold Modulation of Spatial Structure and Function of Hierarchically Porous Nanoparticle@ZIF‐8 Composites to Enhance Field Deployable Disease Diagnostics 2024 ·Small Methods ·Chunyang Li, Yujian Li, (unknown), Li Gui, Juan Li, Yan Zhao, (unknown), (unknown), (unknown), Qing Fu, Jianbo Yuan, Xin Gao, (unknown), Xiaosong Li, (unknown), Zhong Zuo	4
8	Comparison of diclofenac with tramadol, tizanidine or placebo in the treatment of acute low back pain and sciatica: multi-center randomized controlled trial 2024 ·Postgraduate Medical Journal ·Kevin Kei Ching Hung, Rex Pui Kin Lam, Lee Herman, (unknown), (unknown), Zhong Zuo, Ka Chun Chong, (unknown), (unknown), (unknown), (unknown), Catherine Pui Yin Mok, Ling Yan Leung, (unknown), David Sun, Chi Hung Cheng, Colin A. Graham	0
9	A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity 2024 ·Scientific Reports ·(unknown), Rui Lan, Ran Tao, Tao Li, Yuxi Zhu, Yanwei Li, Chuan Zhang, Min Mao, (unknown), Zhong Zuo	1
10	Role of gut microbiota on regulation potential of Dendrobium officinale Kimura & Migo in metabolic syndrome: In-vitro fermentation screening and in-vivo verification in db/db mice 2023 ·Journal of Ethnopharmacology ·(unknown), Sau Wan Cheng, (unknown), (unknown), (unknown), David T. W. Lau, Quan‐Bin Han, Xiao Yang, Pang Chui Shaw, Zhong Zuo	10
11	The Relationship Between Klotho and SIRT1 Expression in Renal Aging Related Disease 2022 ·International Journal of General Medicine ·Hong Hua Su, (unknown), Yanlin Chen, Zhong Zuo	5
12	Achieving Precise Spectral Analysis and Imaging Simultaneously with a Mode-Resolved Dual-Comb Interferometer 2021 ·Sensors ·Zejiang Deng, Yang Liu, Zhiwei Zhu, Daping Luo, Chenglin Gu, Zhong Zuo, (unknown), Wenxue Li	5
13	Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction 2020 ·European Journal of Medicinal Chemistry ·Jiqing Ye, (unknown), Lin Lin, (unknown), (unknown), Min Xiao, Irina Artsimovitch, Zhong Zuo, Cong Ma, Xiao Yang	15
14	Herb-Drug Interactions: Systematic Review, Mechanisms, and Therapies 2015 ·Evidence-based Complementary and Alternative Medicine ·Zhong Zuo, Min Huang, Isadore Kanfer, Moses S. S. Chow, William C. Cho	11
15	Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity 2013 ·BMC Complementary and Alternative Medicine ·(unknown), (unknown), Steven Wang, Zhijun Wang, Charles Wang, Zhong Zuo, (unknown), Leming Shi, Zhining Wen, Ying Huang	33
16	A Prospective Intervention Study on Higher-Dose Oseltamivir Treatment in Adults Hospitalized With Influenza A and B Infections 2013 ·Clinical Infectious Diseases ·Nelson Lee, David S.C. Hui, Zhong Zuo, Karry L. K. Ngai, Grace Lui, (unknown), Wilson Tam, Martin C.W. Chan, Bonnie C. K. Wong, (unknown), Kitty Wai Ying Choi, (unknown), (unknown), Brian Tomlinson, F G Hayden, Paul K.S. Chan	68
17	Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity 2011 ·European Journal of Pharmacology ·Linli Zhou, (unknown), Kwok‐Pui Fung, Christopher H.K. Cheng, Chun-Tao Che, Ming Zhao, Shihua Wu, Zhong Zuo	44
18	Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·Hua Yu, (unknown), Man Chun Cheung, Zhong Zuo, Paul R. Carlier, (unknown), Kelvin Chan, Min Huang, Yi Tao Wang, Yifan Han	2
19	Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use breakdown → 2005 ·The Journal of Clinical Pharmacology ·Limin Zhou, Zhong Zuo, Moses S. S. Chow	1119
20	High-performance liquid chromatographic method for simultaneous determination of baicalein and baicalein 7-glucuronide in rat plasma 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Zhang Li, Ge Lin, Zhong Zuo	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact